{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:13:10Z","timestamp":1792199590628,"version":"4.4.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-32738-9","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T05:45:10Z","timestamp":1765777510000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical feasibility and cost efficiency of perinatal mesenchymal stem cell production under GMP conditions"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2375-6253","authenticated-orcid":false,"given":"Mehmet","family":"\u00c7opuro\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5626-1881","authenticated-orcid":false,"given":"\u00d6mer Tar\u0131k","family":"Yal\u00e7\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7152-5643","authenticated-orcid":false,"given":"S\u00fcleyman G\u00f6khan","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"issue":"5","key":"32738_CR1","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3727\/096368915X689622","volume":"25","author":"T Squillaro","year":"2016","unstructured":"Squillaro, T., Peluso, G. & Galderisi, U. Clinical trials with mesenchymal stem cells: an update. Cell Transplant. 25 (5), 829\u2013848. https:\/\/doi.org\/10.3727\/096368915X689622 (2016).","journal-title":"Cell Transplant."},{"issue":"5411","key":"32738_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger, M. F. et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (5411), 143\u2013147. https:\/\/doi.org\/10.1126\/science.284.5411.143 (1999).","journal-title":"Science"},{"issue":"1","key":"32738_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1186\/s13287-023-03587-y","volume":"14","author":"J Li","year":"2023","unstructured":"Li, J. et al. The heterogeneity of mesenchymal stem cells: an important issue to be addressed in cell therapy. Stem Cell Res. Ther. 14 (1), 381. https:\/\/doi.org\/10.1186\/s13287-023-03587-y (2023).","journal-title":"Stem Cell Res. Ther."},{"issue":"1","key":"32738_CR4","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41392-022-01134-4","volume":"7","author":"DM Hoang","year":"2022","unstructured":"Hoang, D. M. et al. Stem cell-based therapy for human diseases. Signal. Transduct. Target. Therapy. 7 (1), 272. https:\/\/doi.org\/10.1038\/s41392-022-01134-4 (2022).","journal-title":"Signal. Transduct. Target. Therapy"},{"key":"32738_CR5","doi-asserted-by":"publisher","first-page":"956614","DOI":"10.3389\/fbioe.2022.956614","volume":"10","author":"Y Zhu","year":"2022","unstructured":"Zhu, Y. & Fu, W. Peripheral blood-derived stem cells for the treatment of cartilage injuries: A systematic review. Front. Bioeng. Biotechnol. 10, 956614. https:\/\/doi.org\/10.3389\/fbioe.2022.956614 (2022).","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"1","key":"32738_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/prd.12502","volume":"93","author":"G Mizraji","year":"2023","unstructured":"Mizraji, G. et al. Membrane barriers for guided bone regeneration: an overview of available biomaterials. Periodontology 2000. 93 (1), 56\u201376. https:\/\/doi.org\/10.1111\/prd.12502 (2023).","journal-title":"Periodontology 2000"},{"issue":"5","key":"32738_CR7","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.3390\/ijms22052472","volume":"22","author":"CR Harrell","year":"2021","unstructured":"Harrell, C. R., Djonov, V. & Volarevic, V. The cross-talk between mesenchymal stem cells and immune cells in tissue repair and regeneration. Int. J. Mol. Sci. 22 (5), 2472. https:\/\/doi.org\/10.3390\/ijms22052472 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"32738_CR8","doi-asserted-by":"crossref","unstructured":"Merimi, M., El-Majzoub, R., Lagneaux, L., Moussa Agha, D., Bouhtit, F., Meuleman,N., \u2026 Najar, M. (2021). The therapeutic potential of mesenchymal stromal cells for regenerative medicine: Current knowledge and future understandings. Frontiers in Cell and Developmental Biology, 9, 661532. https:\/\/doi.org\/10.3389\/fcell.2021.661532.","DOI":"10.3389\/fcell.2021.661532"},{"issue":"12","key":"32738_CR9","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.3390\/cells10123278","volume":"10","author":"M Kulus","year":"2021","unstructured":"Kulus, M. et al. Mesenchymal stem\/stromal cells derived from human and animal perinatal tissues\u2014Origins, characteristics, signaling pathways, and clinical trials. Cells 10(12), 3278. https:\/\/doi.org\/10.3390\/cells10123278 (2021).","journal-title":"Cells"},{"key":"32738_CR10","doi-asserted-by":"publisher","first-page":"961987","DOI":"10.3389\/fbioe.2022.961987","volume":"10","author":"M Pozzobon","year":"2022","unstructured":"Pozzobon, M. et al. General consensus on multimodal functions and validation analysis of perinatal derivatives for regenerative medicine applications. Frontiers in Bioengineering and Biotechnology 10, 961987. https:\/\/doi.org\/10.3389\/fbioe.2022.961987 (2022).","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"issue":"4","key":"32738_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.4252\/wjsc.v15.i4.105","volume":"15","author":"CH Li","year":"2023","unstructured":"Li, C. H., Zhao, J., Zhang, H. Y. & Wang, B. Banking of perinatal mesenchymal stem\/stromal cells for stem cell-based personalized medicine over lifetime: matters arising. World J. Stem Cells. 15 (4), 105. https:\/\/doi.org\/10.4252\/wjsc.v15.i4.105 (2023).","journal-title":"World J. Stem Cells"},{"issue":"15","key":"32738_CR12","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1080\/15384101.2022.2060641","volume":"21","author":"A Naeem","year":"2022","unstructured":"Naeem, A. et al. A comparison of isolation and culture protocols for human amniotic mesenchymal stem cells. Cell. Cycle. 21 (15), 1543\u20131556. https:\/\/doi.org\/10.1080\/15384101.2022.2060641 (2022).","journal-title":"Cell. Cycle"},{"issue":"1","key":"32738_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3390\/app9010174","volume":"9","author":"S Kargozar","year":"2019","unstructured":"Kargozar, S. et al. Bone tissue engineering using human cells: A comprehensive review on recent trends, current prospects, and recommendations. Appl. Sci. 9 (1), 174. https:\/\/doi.org\/10.3390\/app9010174 (2019).","journal-title":"Appl. Sci."},{"issue":"1","key":"32738_CR14","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s13287-018-0992-0","volume":"9","author":"I Arutyunyan","year":"2018","unstructured":"Arutyunyan, I., Fatkhudinov, T. & Sukhikh, G. Umbilical cord tissue cryopreservation: a short review. Stem Cell Res. Ther. 9 (1), 236. https:\/\/doi.org\/10.1186\/s13287-018-0992-0 (2018).","journal-title":"Stem Cell Res. Ther."},{"issue":"1","key":"32738_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1089\/ten.tec.2021.0207","volume":"28","author":"H Kurogi","year":"2022","unstructured":"Kurogi, H. et al. Study on the umbilical cord-mesenchymal stem cell manufacturing using clinical-grade culture medium. Tissue Engineering Part C: Methods 28(1), 23\u201333. https:\/\/doi.org\/10.1089\/ten.tec.2021.0207 (2022).","journal-title":"Tissue Engineering Part C: Methods"},{"issue":"3","key":"32738_CR16","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1634\/stemcells.2005-0330","volume":"24","author":"ML Weiss","year":"2006","unstructured":"Weiss, M. L. et al. Human umbilical cord matrix stem cells: Preliminary characterization and effect of transplantation in a rodent model of Parkinson\u2019s disease. Stem Cells 24(3), 781\u2013792. https:\/\/doi.org\/10.1634\/stemcells.2005-0330 (2006).","journal-title":"Stem Cells"},{"issue":"6","key":"32738_CR17","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S1472-6483(10)60539-1","volume":"15","author":"CY Fong","year":"2007","unstructured":"Fong, C. Y., Richards, M., Manasi, N., Biswas, A. & Bongso, A. Comparative growth behaviour and characterization of stem cells from human wharton\u2019s jelly. Reprod. Biomed. Online. 15 (6), 708\u2013718. https:\/\/doi.org\/10.1016\/S1472-6483(10)60539-1 (2007).","journal-title":"Reprod. Biomed. Online"},{"issue":"7","key":"32738_CR18","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1634\/stemcells.2004-0058","volume":"22","author":"PS In\u2019t Anker","year":"2004","unstructured":"In\u2019t Anker, P. S. et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells. 22 (7), 1338\u20131345. https:\/\/doi.org\/10.1634\/stemcells.2004-0058 (2004).","journal-title":"Stem Cells"},{"issue":"2","key":"32738_CR19","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s13577-023-01008-z","volume":"37","author":"N Liu","year":"2024","unstructured":"Liu, N. et al. Tissue-specific populations from amniotic fluid-derived mesenchymal stem cells manifest variant in vitro and in vivo properties. Human Cell 37(2), 408\u2013419. https:\/\/doi.org\/10.1007\/s13577-023-01008-z (2024).","journal-title":"Human Cell"},{"issue":"10","key":"32738_CR20","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1007\/s10529-021-03180-4","volume":"43","author":"S Rallapalli","year":"2021","unstructured":"Rallapalli, S. et al. A critical appraisal of humanized alternatives to fetal bovine serum for clinical applications of umbilical cord derived mesenchymal stromal cells. Biotechnol. Lett. 43 (10), 2067\u20132083. https:\/\/doi.org\/10.1007\/s10529-021-03180-4 (2021).","journal-title":"Biotechnol. Lett."},{"key":"32738_CR21","doi-asserted-by":"publisher","first-page":"101739","DOI":"10.1016\/j.bbrep.2024.101739","volume":"39","author":"X Deng","year":"2024","unstructured":"Deng, X. et al. Distinct biological characteristics of mesenchymal stem cells separated from different components of human placenta. Biochemistry and Biophysics Reports 39, 101739. https:\/\/doi.org\/10.1016\/j.bbrep.2024.101739 (2024).","journal-title":"Biochemistry and Biophysics Reports"},{"key":"32738_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.bej.2018.02.018","volume":"135","author":"A Mizukami","year":"2018","unstructured":"Mizukami, A. et al. Technologies for large-scale umbilical cord-derived MSC expansion: experimental performance and cost of goods analysis. Biochem. Eng. J. 135, 36\u201348. https:\/\/doi.org\/10.1016\/j.bej.2018.02.018 (2018).","journal-title":"Biochem. Eng. J."},{"issue":"8","key":"32738_CR23","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3390\/cells8080886","volume":"8","author":"Y Han","year":"2019","unstructured":"Han, Y. et al. Mesenchymal stem cells for regenerative medicine. Cells 8 (8), 886. https:\/\/doi.org\/10.3390\/cells8080886 (2019).","journal-title":"Cells"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32738-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32738-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32738-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:10:24Z","timestamp":1769213424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32738-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["32738"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-32738-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Eski\u015fehir Osmangazi University Clinical Research Ethics Committee (Approval No: 28; Date: August 3, 2023). Written informed consent was obtained from all participants prior to sample collection, in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"2791"}}